Vaccitech

A clinical stage T cell immunotherapy company developing products to target cancer, infectious and autoimmune diseases

[Vaccitech @Vaccitechplc]

#NEWS: Vaccitech is now @BarinthusBio! Listen to CEO, @benrights, explain the meaning behind our new name. Learn more: https://t.co/50p1EhrX3G #innovation #immunotherapy

[The Pharma Letter @ThePharmaLetter]

Vaccitech rebrands as @BarinthusBio https://t.co/OmN0aGENyG

[European Pharmaceutical Review @PharmaReview]

Graham Griffiths of @Vaccitechplc discusses lessons from #vaccine and drug development during the pandemic, as well as the importance of collaboration in #pandemic preparedness. Read more:
https://t.co/jyeiHASgEX

#DrugDevelopment #EPRTalks

[Vaccitech @Vaccitechplc]

Congratulations to the team for the publication of their paper in Vaccines journal! Respiratory syncytial virus (#RSV) infection and #shingles are two viral diseases that affect older adults - read the full paper here: https://t.co/vpJbrN3uuN
#biotech #innovation

[Vaccitech @Vaccitechplc]

Our CBO, Graham Griffiths, is at The World Vaccine Congress with our founder Dame Sarah Gilbert, where she has been talking about #pandemic preparedness, as well as discussing the 'The Future of Vaccines - Discovery to Delivery' with @biztradegovuk.
#WVC2023 #biotech $VACC

[Vaccitech @Vaccitechplc]

Learn more about our #prostatecancer multi-platform approach immunotherapeutic candidate, VTP-850, currently in phase 1/2 clinical trials: https://t.co/YHUrs5hqLY $VACC

[Vaccitech @Vaccitechplc]

Our CEO, @benrights was recently profiled by @YoungBiotech. He talks about his 30+ years in both privately held and publicly traded companies and explains how part of his career felt like “indoctrination by fire.” Read more here: https://t.co/9M1QOD06pX $VACC

[Vaccitech @Vaccitechplc]

.@contagion_live recently spoke with CSO Nadege Pelletier, discussing our HBV immunotherapeutic candidate, VTP-300, and the work towards a component for functional cure for #hepatitisB: https://t.co/aV3U9kMyl5

$VACC #womeninbiotech

[Contagion @Contagion_Live]

.@Vaccitechplc has developed an immunotherapy platform to provide a functional cure for HBV. #hepatitis b #livertwitter

https://t.co/etpEcjqslD

[Vaccitech @Vaccitechplc]

Middle East Respiratory Syndrome (MERS) is a viral respiratory illness that is transferred to humans from infected dromedary camels and has the potential to pose a #pandemic threat - it's great to see @PSIOxford pushing this research forward!

[Pandemic Sciences Institute @PSIOxford]

📢 NEWS: Scientists from Oxford & Liverpool launch new vaccine trial for Middle East Respiratory Syndrome (MERS).

#MERS is a deadly viral illness with no current vaccines, posing a potential #pandemic threat.

Read the full story ⬇️

https://t.co/R1ccSEhfII

[Vaccitech @Vaccitechplc]

Join us for a webinar on September 20th featuring world experts in #hepatitisB, Dr. @EleanorBarnesOx & Dr. Ed Gane. They'll discuss progress being made in HBV treatments, like combination approaches to enhancing rates of functional cure: https://t.co/qHw4DvPjBG

$VACC #meded

[Vaccitech @Vaccitechplc]

Our CEO @benrights recently penned an article in @Biospace discussing how Vaccitech has built a global #biopharma presence on both sides of the pond. Read more: https://t.co/yTQoZSSr5O

$VACC

[Vaccitech @Vaccitechplc]

We’re looking forward to sitting down for a fireside chat today at this year’s @MorganStanley Annual Global Healthcare Conference at 11:30am ET in New York City. We look forward to seeing you there!
#investors #biotech $VACC

[Vaccitech @Vaccitechplc]

#DYK Only 30% of people with #celiac are properly diagnosed. https://t.co/rweNzOCc1D #NationalCeliacDiseaseAwarenessDay

[Vaccitech @Vaccitechplc]

International #HepB experts Drs. @EleanorBarnesOx & Ed Gane, will participate in our #keyopinionleader webinar next week discussing the current treatment landscape and the potential of an antigen-specific immunotherapeutic approach. Register here: https://t.co/B7XcEAkIlH $VACC

[LifeSci Advisors @LifeSciAdvisors]

Join us on September 20th at 2pm ET for a KOL Webinar with @Vaccitechplc ( $VACC ), featuring Dr. Eleanor Barnes and Dr. Ed Gane, discussing #HBV and the potential of the antigen-specific immunotherapeutic approach.

RSVP: https://t.co/rPZpnhrwST

[Vaccitech @Vaccitechplc]

We’re looking forward to presenting today at this year’s H.C. Wainwright Annual Global Investment Conference in New York City. Join us in person or virtually today at 09:30am to learn more: https://t.co/YAQoMWio7C
#biotech #immunotherapy $VACC #investorconference #investors

[Vaccitech @Vaccitechplc]

Tomorrow! Our CEO @benrights will be speaking about #organizationaldesign with an array of business leaders across diverse sectors. Click the link below👇 to sign up for the webinar hosted by @CultureWorksLPD. $VACC

[Culture Works Consortium @CultureWorksLPD]

Elevate Your Business with Strategic Organisational Design! 📈

Be part of our FREE webinar tomorrow (7th September) at 12:30 PM (BST). Bill Enright (Vaccitech) & Andrew Lee (888Africa & Voxbet) join Michael and Guy to share insights on creating a thriving culture for growth.

[Vaccitech @Vaccitechplc]

#DYK that prostate cancer is the second most common cancer among men? About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Learn more about risk factors and screening: https://t.co/bUUooD07IA #ProstateCancerAwarenessMonth.

[Vaccitech @Vaccitechplc]

#DYK we’re on both sides of the pond? Vaccitech’s U.S. office, located in Germantown, MD, is designed to enable the research and development programs in #polymerdrug delivery, as well as advancement of the SNAPvax team: https://t.co/gSzKYERUUW $VACC

[Culture Works Consortium @CultureWorksLPD]

Discover how to strategically reshape your company's culture for growth with insights from Bill Enright (Vaccitech) & Andrew Lee (888Africa & Voxbet) as well as our CEO Michael Short and Associate Guy Pearson.

[Vaccitech @Vaccitechplc]

Our HBV candidate, VTP-300, is the first antigen-specific #immunotherapy that’s been shown to induce sustained reductions in #HepatitisB surface antigen. Innovative research like this offers hope to those with chronic HBV.

Learn more: https://t.co/g8SEXTg3Kv

$VACC